From quantum bits to drug hits: A new way to target KRAS
Live Forever Club - 17-Dec-2025A hybrid quantum–AI system designed and validated new KRAS inhibitors in early lab tests
Join the club for FREE to access the whole archive and other member benefits.
A hybrid quantum–AI system designed and validated new KRAS inhibitors in early lab tests
OpenAI-backed Chai raises $130M to accelerate drug and antibody design with AI
Tiny autonomous machines could one day navigate the body to deliver treatments and repair tissue
A soft, low-cost robot performs precise beating-heart procedures in minutes
Robotics pioneer Fred Moll backs AI-powered machines to expand access to complex surgery worldwide
Personalized coaching boosts healthy habits and self-care for multimorbidity patients
New radiopaque models mimic real tissue on scans, making imaging education cheaper and repeatable
Blood-based circRNA signatures aim to spot Alzheimer’s risk years before symptoms appear
Early evidence shows magnetic therapy may aid blood sugar control in centrally obese diabetics
ISM3830 boosts immune attack and delivers strong preclinical tumour control
Generative AI may soon enable robots to perform safe, precise operations on their own
Bacterial blood metabolites may naturally shield skin from inflammation and aging-related damage
Tiny light-powered chips ride immune cells into the brain to deliver targeted stimulation
Custom 3D printing at Mayo speeds surgery prep and delivers safer, patient-specific care
Lila Sciences aims to speed up breakthroughs by pairing powerful AI with massive robotic labs
VCPI will generate massive high-quality pharmacology data to standardize virtual cell models
Metabolic fingerprints from 500,000 people reveal risks 10–15 years before illness
Lab-grown corneal implant safely integrated and returned sight in initial human use
Natural nozzle enables micro-scale 3D printing at under one dollar each
New Hevolution–Nanobiosym deal accelerates AI-driven metabolic and ageing diagnostics
New DNA origami nanorobots can store energy and perform multistep tasks without external power
AI-driven experiments will map how molecules penetrate tough Gram-negative bacteria
Ageing clocks reveal 27% more drug targets, speeding multi-disease therapy
Startup uses transcription factor mapping to find disease-modifying treatments for neurodegeneration
AbbVie ends its $1.75B Calico deal after the ALS drug fosigotifator failed in phase 2/3 trials